We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LILAK:NASDAQLiberty Latin America Ltd. analysis

Data as of Oct 10, 2026 - not real-time

Latest price
$8.12
Risk: medium
5/10Medium risk

Summary

Liberty Latin America Ltd. is priced at $8.12 and its moving averages line up in bullish order, the shorter sitting above the longer. It has lost 1.8% over the past 30 days. Momentum indicators put RSI at 40.6 (neutral) with MACD reading bearish. Price has been bracketed by support at $8.07 and resistance at $8.99.
On valuation the read is overvalued — earnings multiple of 19.8 versus a 15.2 sector average, above the peer group. Consensus targets land 11.3% below where the shares trade now.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 35.7%, a beta of 0.20 and a maximum drawdown of 22.6%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against sell longer out, with 5/10 conviction on the long call.

Top market events

  • Read Liberty Latin America Ltd. LILAK Q2 FY2026 earnings call transcript on Yahoo Finance to keep your investing...
  • DENVER, Colorado, July 27, 2026--Liberty Latin America Ltd.
  • Liberty Latin America stock has climbed more than 60 percent over the past 16 months, supported by a

Market outlook

Short term

< 1 year

Neutral

Model confidence1/101 out of 10

Key factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 6.45
  • MACD momentum is negative

Medium term

1–3 years

Neutral

Model confidence3/103 out of 10

Key factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 19.8 versus sector average of 15.2
  • Trading above the 200-day average of 6.45

Long term

> 3 years

Cautious

Model confidence5/105 out of 10

Key factors

  • P/E of 19.8 versus sector average of 15.2
  • Negative profit margin of -2.2%
  • Analyst targets imply -11.3% versus the current price

Key metrics

Financial health

Revenue Growth1.50%
Profit Margin-2.20%
P/E Ratio19.8
ROE-3.72%
ROA1.28%
Debt/Equity905.53
P/B Ratio3.1
Op. Cash Flow$899.1M
Free Cash Flow$431.2M
Industry P/E15.2

Technical analysis

TrendBullish
RSI40.6
Support$8.07
Resistance$8.99
MA 20$8.57
MA 50$8.50
MA 200$6.45
MACDBearish
VolumeStable
Fear & Greed Index94.93

Valuation

Target Price$7.20
Upside/Downside-11.33%
GradeOvervalued
TypeBlend

Risk assessment

Beta0.20
Volatility35.69%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.